HOWL Werewolf: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Werewolf Therapeutics Inc. (HOWL)

The minimal predictability of Werewolf Therapeutics cash flows due to its research stage is evident in the EV/Sales ratio trend, where the parameter has settled at 287.62. Business stability is based on the INDUKINE platform and partnerships with industry behemoths. The capitalization of HOWL currently depends on internal development cycles and the results of early trials of new cancer-fighting molecules.

Nilai perusahaan marang pendapatan: Werewolf (HOWL) kanggo 23.11.2025 - 20.11.2026

Werewolf - rincian analitis lan metrik utama (HOWL)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Werewolf Therapeutics Inc. HOWL
Sampel barang Werewolf Therapeutics Inc.

The EV/Sales ratio measures business value relative to annual revenue, excluding the impact of debt load to reveal the actual market valuation of assets. By analyzing the EV/Sales history, an investor sees the current value of 287.62, which, combined with the protected legal status of Werewolf Therapeutics (HOWL) biologics in the US, minimizes the risk of a "value trap" when determining consolidation boundaries.

Analisis pesaing Werewolf Therapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP